Status:
UNKNOWN
Galantamine in the Treatment of Post-Traumatic Headache
Lead Sponsor:
Rapoport, Alan, M.D.
Collaborating Sponsors:
Ortho-McNeil Neurologics, Inc.
Conditions:
Post-Traumatic Headache
Head Trauma,Closed
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Most patients with CPTH present with additional major cognitive, behavioral and somatic problems. Most drugs used currently have a negative influence on cognition. Therefore, treatment strategies addr...
Detailed Description
Headache is the most common symptom after a closed head injury, persisting for more then 2 months in 60% of the patients. CPTH is an important cause of consultations in neurology offices and headache ...
Eligibility Criteria
Inclusion
- Age range 18-75 CPTH according to ICHD-2 Fertile woman using adequate birth control Willing and able to give informed consent Willing and able to complete the entire course of the study to comply with study instructions Stable does of preventive medication
- \-
Exclusion
- Subject is pregnant or lactating Significant medical or psychiatric disease Previous failure to 4 or more adequate trials of preventive medication Patient on non-stable dose of medication used to prevent CPTH
- \-
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00219869
Start Date
July 1 2005
End Date
August 1 2005
Last Update
September 22 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The New England Center for Headache
Stamford, Connecticut, United States, 06902